Variation Interpretation Predictors: Principles, Types, Performance, and Choice
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Next-generation sequencing methods have revolutionized the speed of generating variation information. Sequence data have a plethora of applications and will increasingly be used for disease diagnosis. Interpretation of the identified variants is usually not possible with experimental methods. This has caused a bottleneck that many computational methods aim at addressing. Fast and efficient methods for explaining the significance and mechanisms of detected variants are required for efficient precision/personalized medicine. Computational prediction methods have been developed in three areas to address the issue. There are generic tolerance (pathogenicity) predictors for filtering harmful variants. Gene/protein/disease-specific tools are available for some applications. Mechanism and effect-specific computer programs aim at explaining the consequences of variations. Here, we discuss the different types of predictors and their applications. We review available variation databases and prediction methods useful for variation interpretation. We discuss how the performance of methods is assessed and summarize existing assessment studies. A brief introduction is provided to the principles of the methods developed for variation interpretation as well as guidelines for how to choose the optimal tools and where the field is heading in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · cited 1×
“The 20/20 rule was derived to identify oncogenes and tumor-suppressor genes based on whether there are recurrent variations or the variations are distributed along the protein sequences [Vogelstein et al., 2013].”
BackgrounddbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461 · cited 1×
“Large numbers of false positives could be identified due to high mutation rates in many cancers and many false negatives due to tumor heterogeneity [Lawrence et al., 2013].”
BackgroundUniProt: a hub for protein information
The UniProt Consortium (2015) · Nucleic Acids Research · doi:10.1093/nar/gku989 · Cited by 5,106
Pan, Q., Shai, O., Lee, L. J., Frey, B. J., & Blencowe, B. J. (2008) · Nature Genetics · doi:10.1038/ng.259 · Cited by 3,951 · cited 2×
“At least about 95% of human genes have more than one transcript [Pan et al., 2008]; however, many of them are extremely rare and their biological significance has not been established.”
BackgroundClinVar: public archive of relationships among sequence variation and human phenotype
Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1113 · Cited by 3,516
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184 · cited 2×
“uk/genetics/CGP/Census/) lists genes implicated in cancer [Futreal et al., 2004].”
BackgroundPredicting the Functional Effect of Amino Acid Substitutions and Indels
Choi, Y., Sims, G. E., Murphy, S., Miller, J. R., & Chan, A. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046688 · Cited by 2,890
The FoldX web server: an online force field
Schymkowitz, J., Borg, J., Stricher, F., Nys, R., Rousseau, F., & Serrano, L. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki387 · Cited by 2,759
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610 · cited 2×
“MutSigCV [Lawrenceetal.,2013],MuSiC[Deesetal.,2012],andInVEx[Hodis etal.,2012]identifygenescontainingasignificantlyhighervariation frequencycomparedwiththebackgroundmutationrate.”
BackgroundPredicting effects of noncoding variants with deep learning–based sequence model
Zhou, J., & Troyanskaya, O. G. (2015) · Nature Methods · doi:10.1038/nmeth.3547 · Cited by 2,338
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278 · cited 4×
“Variations have been identified in these genes, available in the COSMIC database [Forbes et al., 2011].”
BackgroundMethodInfluentialListening to silence and understanding nonsense: exonic mutations that affect splicing
Cartegni, L., Chew, S. L., & Krainer, A. R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg775 · Cited by 2,209 · cited 3×
“CADD [Kircher et al., 2014], MutationTaster2 [Schwarz et al., 2014], PROVEAN [Choi et al., 2012], and VEST [Carter et al., 2013; Douville et al., 2016] can predict impacts of insertions, deletions, as well as amino acid substitutions.”
BackgroundAssessing the accuracy of prediction algorithms for classification: an overview
Baldi, P., Brunak, S., Chauvin, Y., Andersen, C. A. F., & Nielsen, H. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.5.412 · Cited by 2,111
Intrinsic Disorder and Protein Function
Dunker, A. K., Brown, C. J., Lawson, J. D., Iakoucheva, L. M., & Obradović, Z. (2002) · Biochemistry · doi:10.1021/bi012159+ · Cited by 1,731
Guerois, R., Nielsen, J. E., & Serrano, L. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00442-4 · Cited by 1,728 · cited 3×
“The energy function-based methods can be grouped into physical potential function, statistical potential function, and empirical potential function methods [Guerois et al., 2002; Capriotti et al., 2004; Parthiban et al., 2006].”
MethodDistribution and intensity of constraint in mammalian genomic sequence
Cooper, G. M., Stone, E. A., Asimenos, G., Green, E. D., Batzoglou, S., & Sidow, A. (2005) · Genome Research · doi:10.1101/gr.3577405 · Cited by 1,359
The human phenotype ontology: a tool for annotating and analyzing human hereditary disease
Robinson, P. N., Köhler, S., Bauer, S., Seelow, D., Horn, D., & Mundlos, S. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.017 · Cited by 1,034 · cited 3×
“It is recommended to use systematics in variation databases whenever possible, including those for phenotype such as the Human Phenotype Ontology (HPO) [Robinson et al., 2008] and the Variation Ontology (VariO) [Vihinen, 2014b] for a systematic description of effects, mechanisms, and consequences of variants.”
MethodUnderstanding the contribution of synonymous mutations to human disease
Sauna, Z. E., & Kimchi-Sarfaty, C. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3051 · Cited by 1,022 · cited 2×
“…with disease, other types of variations including synonymous variations (that do not alter amino acid sequence) are associated with several diseases [Sauna and Kimchi-Sarfaty, 2011], for example, by altering splicing, changing mRNA structure, or changing translation speed [Hunt et al., 2014].”
BackgroundPires, D. E. V., Ascher, D. B., & Blundell, T. L. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku411 · Cited by 932
Plon, S. E., Eccles, D. M., Easton, D., Foulkes, W. D., Genuardi, M., Greenblatt, M. S., Hogervorst, F. B. L., Hoogerbrugge, N., Spurdle, A. B., Tavtigian, S. V., et al. (2008) · Human Mutation · doi:10.1002/humu.20880 · Cited by 912
Zhou, H., & Zhou, Y. (2002) · Protein Science · doi:10.1110/ps.0217002 · Cited by 902 · cited 2×
“, 2008], Dmutant [Zhou and Zhou, 2002], and FoldX [Schymkowitz et al.”
MethodInfluentialWidespread macromolecular interaction perturbations in human genetic disorders
Sahni, N., Yi, S., Taipale, M., Fuxman Bass, J. I., Coulombe-Huntington, J., Yang, F., Peng, J., Weile, J., Karras, G. I., Wang, Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.013 · Cited by 594 · cited 1×
“For example, many variants that have stable structures affect molecular interactions [Sahni et al., 2015].”
BackgroundPerformance of mutation pathogenicity prediction methods on missense variants
Thusberg, J., Olatubosun, A., & Vihinen, M. (2011) · Human Mutation · doi:10.1002/humu.21445 · Cited by 537
Self-citationThe CamSol method of rational design of protein mutants with enhanced solubility
Sormanni, P., Aprile, F. A., & Vendruscolo, M. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.09.026 · Cited by 494 · cited 3×
“OptSolMut and CamSol require a known 3-”
Variation in the mutation rate across mammalian genomes
Hodgkinson, A., & Eyre-Walker, A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3098 · Cited by 487
Grimm, D. G., Azencott, C., Aicheler, F., Gieraths, U., MacArthur, D. G., Samocha, K. E., Cooper, D. N., Stenson, P. D., Daly, M. J., Smoller, J. W., et al. (2015) · Human Mutation · doi:10.1002/humu.22768 · Cited by 356 · cited 2×
“A study of 10 prediction methods that were evaluated with five datasets [Grimm et al., 2015] revealed that the performance of methods decreases when the variations present in the methods’ training dataset were eliminated from the test data.”
MethodPotapov, V., Cohen, M., & Schreiber, G. (2009) · Protein Engineering Design and Selection · doi:10.1093/protein/gzp030 · Cited by 349
Houdayer, C., Caux-Moncoutier, V., Krieger, S., Barrois, M., Bonnet, F., Bourdon, V., Bronner, M., Buisson, M., Coulet, F., Gaildrat, P., et al. (2012) · Human Mutation · doi:10.1002/humu.22101 · Cited by 239 · cited 2×
“In another study, the performance of the same six tools was assessed using 272 variations in the BRCA1 and BRCA2 genes [Houdayer et al., 2012].”
MethodTowards precision medicine: advances in computational approaches for the analysis of human variants
Peterson, T. A., Doughty, E., & Kann, M. G. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.08.008 · Cited by 123
Vreeswijk, M. P. G., Kraan, J. N., van der Klift, H. M., Vink, G. R., Cornelisse, C. J., Wijnen, J. T., Bakker, E., van Asperen, C. J., & Devilee, P. (2009) · Human Mutation · doi:10.1002/humu.20811 · Cited by 98 · cited 1×
“Splicing effect predictors have been assessed in several studies [Houdayer et al., 2008; Holla et al., 2009; Vreeswijk et al., 2009; Thery et al., 2011; Houdayer et al., 2012; Grodecka et al., 2014].”
MethodThompson, B. A., Greenblatt, M. S., Vallee, M. P., Herkert, J. C., Tessereau, C., Young, E. L., Adzhubey, I. A., Li, B., Bell, R., Feng, B., et al. (2013) · Human Mutation · doi:10.1002/humu.22214 · Cited by 95
Describing structural changes by extending HGVS sequence variation nomenclature
Taschner, P. E. M., & den Dunnen, J. T. (2011) · Human Mutation · doi:10.1002/humu.21427 · Cited by 61
Cited by
Inferring the molecular and phenotypic impact of amino acid variants with MutPred2
Pejaver, V., Urresti, J., Lugo-Martinez, J., Pagel, K. A., Lin, G. N., Nam, H.-J., Mort, M., Cooper, D. N., Sebat, J., Iakoucheva, L. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19669-x · Cited by 923
Schubach, M., Maass, T., Nazaretyan, L., Röner, S., & Kircher, M. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad989 · Cited by 455
“CADD has been widely adopted in the field of genomics and variant interpretation, aiding researchers and clinicians in prioritizing genetic variants for further analysis, especially in the context of disease-causing variants and personalized medicine applications ( 21–23 ).”
BackgroundMachine Learning in Enzyme Engineering
Mazurenko, S., Prokop, Z., & Damborsky, J. (2020) · ACS Catalysis · doi:10.1021/acscatal.9b04321 · Cited by 410
ClinPred: Prediction Tool to Identify Disease-Relevant Nonsynonymous Single-Nucleotide Variants
Alirezaie, N., Kernohan, K. D., Hartley, T., Majewski, J., & Hocking, T. D. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.08.005 · Cited by 270
Problems in variation interpretation guidelines and in their implementation in computational tools
Vihinen, M. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1206 · Cited by 22
Self-citation
Metadata
- Authors
- Niroula, A., & Vihinen, M.
- Venue
- Human Mutation
- Publisher
- Wiley
- Published
- 2016-04-15
- Volume
- 37
- Issue
- 6
- Pages
- 579-597
- ISSN
- 1059-7794 (ISSN-L)
- OpenAlex
- W2310980987
- Cited by
- 125
- References
- 36
- FWCI
- 14.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.